Actimmune — Medical Mutual

Initial criteria

• Diagnosis has been established by a molecular genetic test identifying a gene-related pathogenic variant linked to chronic granulomatous disease; AND
• The medication is prescribed by, or in consultation with, an immunologist

Approval duration

1 year